Resolving Unreported Conflicts of Interest

被引：24

作者：

DeAngelis, Catherine D.

Fontanarosa, Phil B.

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2009年 / 302卷 / 02期

关键词：

INCOMPLETE FINANCIAL DISCLOSURE;

D O I：

10.1001/jama.302.2.198

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：198 / 199

页数：2

共 13 条

[1]

*AAMC, PROT PAT PRES INT AD

[2] Impugning the integrity of medical science - The adverse effects of industry influence [J].

DeAngelis, Catherine D. ;

Fontanarosa, Phil B. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (15) :1833-1835

[3] Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. (Retraction of JAMA, vol 299, pg 1669, 2008) [J].

DeAngelis, Catherine D. ;

Fontanarosa, Phil B. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (18) :1931-1931

[4] Update on JAMA's conflict of interest policy [J].

Flanagin, Annette ;

Fontanarosa, Phil B. ;

DeAngelis, Catherine D. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (02) :220-221

[5] Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies [J].

Fontanarosa, PB ;

Flanagin, A ;

DeAngelis, CD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (01) :110-111

[6]

GILES J, 2009, NEW SCI FEB

[7]

HARRIS G, 2008, NY TIMES 1003

[8]

Institute of Medicine, 2009, DETAILED RULES COMMO

[9]

NATANSON C, 2008, JAMA, V300, P1300

[10] Incomplete financial disclosure for study of funding and outcomes in major cardiovascular trials [J].

Ridker, Paul M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (23) :2725-2726

← 1 2 →